OPFYND
LIVE

Serial Number

99454074

Owner

Merck Sharp & Dohme B.V.

Attorney

Palak Mayani

Filing Date

Oct 21, 2025

Add to watchlist:

No watchlists yet
View on USPTO

OPFYND Trademark

Serial Number: 99454074 • Registration: 8242660

OPFYND is a trademark filed by Merck Sharp & Dohme B.V. on October 21, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Merck Sharp & Dohme B.V. (40 trademarks)

Waarderweg 39
HAARLEM 2031BN , NL

Entity Type: 26

Trademark Details

Filing Date

October 21, 2025

Registration Date

May 5, 2026

Published for Opposition

March 17, 2026

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 5, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 5, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 23, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 9, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 21, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 21, 2026 GNSL
SUSPENSION LETTER WRITTEN
Jan 21, 2026 CNSL
ASSIGNED TO EXAMINER
Jan 8, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 21, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2025 NWOS
NEW APPLICATION ENTERED
Oct 21, 2025 NWAP